•
AT
ATRC
AtriCure, Inc.
polygonSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
1.95B
Volume
17.91K
52W High
$43.18
52W Low
$28.29
Open
$39.30
Prev Close
$39.27
Day Range
39.07 - 39.63
About AtriCure, Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Latest News
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
The Motley Fool•Nov 29
Questex’s Fierce Healthcare Announces 2025 Fierce DEI Award Finalists
GlobeNewswire Inc.•May 14
AtriCure gains China's nod for heart surgery device - Investing.com
Investing.com•Jul 23
Cracking The Code: Understanding Analyst Reviews For AtriCure
Benzinga•May 2
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research•May 2
AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 1
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
Zacks Investment Research•Apr 19
Key Takeaways From AtriCure Analyst Ratings
Benzinga•Apr 10